Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
44,885,687
-
Share change
-
+2,691,543
-
Total reported value
-
$313,749,028
-
Price per share
-
$6.99
-
Number of holders
-
53
-
Value change
-
+$16,464,867
-
Number of buys
-
23
-
Number of sells
-
18
Institutional Holders of AMRYT PHARMA PLC - SPONSORED ADS (AMYT) as of Q2 2022
As of 30 Jun 2022,
AMRYT PHARMA PLC - SPONSORED ADS (AMYT) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,885,687 shares.
The largest 10 holders included
Athyrium Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Stonepine Capital Management, LLC, Rubric Capital Management LP, MPM ASSET MANAGEMENT LLC, EdgePoint Investment Group Inc., UBS OCONNOR LLC, Aquilo Capital Management, LLC, Nantahala Capital Management, LLC, and Handelsbanken Fonder AB.
This page lists
53
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.